1. Home
  2. AXR vs ELTX Comparison

AXR vs ELTX Comparison

Compare AXR & ELTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AXR
  • ELTX
  • Stock Information
  • Founded
  • AXR 1961
  • ELTX 2011
  • Country
  • AXR United States
  • ELTX United States
  • Employees
  • AXR N/A
  • ELTX N/A
  • Industry
  • AXR Homebuilding
  • ELTX Biotechnology: Pharmaceutical Preparations
  • Sector
  • AXR Real Estate
  • ELTX Health Care
  • Exchange
  • AXR Nasdaq
  • ELTX Nasdaq
  • Market Cap
  • AXR 110.0M
  • ELTX 121.7M
  • IPO Year
  • AXR N/A
  • ELTX N/A
  • Fundamental
  • Price
  • AXR $21.79
  • ELTX $5.40
  • Analyst Decision
  • AXR
  • ELTX Strong Buy
  • Analyst Count
  • AXR 0
  • ELTX 2
  • Target Price
  • AXR N/A
  • ELTX $9.50
  • AVG Volume (30 Days)
  • AXR 13.1K
  • ELTX 35.2K
  • Earning Date
  • AXR 03-07-2025
  • ELTX 05-19-2025
  • Dividend Yield
  • AXR N/A
  • ELTX N/A
  • EPS Growth
  • AXR 472.07
  • ELTX N/A
  • EPS
  • AXR 2.41
  • ELTX N/A
  • Revenue
  • AXR $58,052,000.00
  • ELTX N/A
  • Revenue This Year
  • AXR N/A
  • ELTX N/A
  • Revenue Next Year
  • AXR N/A
  • ELTX N/A
  • P/E Ratio
  • AXR $9.09
  • ELTX N/A
  • Revenue Growth
  • AXR 30.35
  • ELTX N/A
  • 52 Week Low
  • AXR $15.88
  • ELTX $3.34
  • 52 Week High
  • AXR $39.67
  • ELTX $11.45
  • Technical
  • Relative Strength Index (RSI)
  • AXR 47.78
  • ELTX 48.43
  • Support Level
  • AXR $21.15
  • ELTX $4.85
  • Resistance Level
  • AXR $22.97
  • ELTX $5.94
  • Average True Range (ATR)
  • AXR 1.06
  • ELTX 0.50
  • MACD
  • AXR -0.09
  • ELTX 0.14
  • Stochastic Oscillator
  • AXR 23.78
  • ELTX 56.45

About AXR AMREP Corporation

Amrep Corp through its subsidiaries is engaged in the Real estate business. Its activities include land sales and lease activities, which involve the obtaining of approvals and the sale of both developed and undeveloped lots to homebuilders, commercial users, and others, as well as investments in commercial and investment properties. Its operating segments include Land development and Homebuilding. The firm generates a majority of its revenue from the Land development segment. Geographically, all the activities are carried out throughout the United States.

About ELTX Elicio Therapeutics Inc.

Elicio Therapeutics Inc is a clinical-stage biotechnology company pioneering the development of cancer immunotherapies for patients with limited treatment options and poor outcomes. Its proprietary Amphiphile, or AMP, platform delivers investigational immunotherapeutics directly to the brain center of the immune system the lymph nodes. Its focus is the development of cancer immunotherapies against biologically validated but hard-to-drug targets that can be activated through lymph node trafficking. Elicio is engineering lymph node-targeted AMPlifiers, immunomodulators, adjuvants, and vaccines for an array of aggressive cancers. It has developed its cancer vaccine product candidates to target biologically validated tumor mutation drivers using known neoantigens.

Share on Social Networks: